Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients-An Open-Label Phase II Clinical Trial.

As an example, a subgroup analysis of the RECOVERY data for patients without the use of corticosteroids (indicative of earlier disease stage) showed a trend toward fewer deaths at 28 days in the CCP versus the control groups (19% vs. 24%, respectively).

also in 53,322 other papers